Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Implications for Pathogenesis and Treatment
Shan Liu, Jiguo Gao, Mingqin Zhu, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 5026-5043
Open Access | Times Cited: 333

Showing 1-25 of 333 citing articles:

Neuroinflammation in Alzheimer’s Disease
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 204
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Qing Wang, Yuqi Luo, К. Ray Chaudhuri, et al.
Brain (2021) Vol. 144, Iss. 9, pp. 2571-2593
Open Access | Times Cited: 187
The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Angelica Varesi, Elisa Pierella, Marcello Romeo, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 668-668
Open Access | Times Cited: 165
Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation Strategies
Umair Shabbir, Muhammad Sajid Arshad, Aysha Sameen, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 690-690
Open Access | Times Cited: 144
Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Min’an Zhao, Jiayi Chu, Shiyao Feng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114985-114985
Open Access | Times Cited: 130
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 129
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Emily Connell, Gwénaëlle Le Gall, Matthew G. Pontifex, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 126
Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis
Stefanie Grabrucker, Moira Marizzoni, Edina Silajdžić, et al.
Brain (2023) Vol. 146, Iss. 12, pp. 4916-4934
Open Access | Times Cited: 113
Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis
Jody Rusch, Brian T. Layden, Lara R. Dugas
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 112
Vagus Nerve and Underlying Impact on the Gut Microbiota-Brain Axis in Behavior and Neurodegenerative Diseases
Yimin Han, Boya Wang, Han Gao, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 6213-6230
Open Access | Times Cited: 98
The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer’s disease: A narrative review
Emma Aaldijk, Yannick Vermeiren
Ageing Research Reviews (2022) Vol. 75, pp. 101556-101556
Open Access | Times Cited: 92
Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases
Tanja Patricia Eicher, M. Hasan Mohajeri
Nutrients (2022) Vol. 14, Iss. 13, pp. 2661-2661
Open Access | Times Cited: 81
The Role of Microbiome in Brain Development and Neurodegenerative Diseases
Varsha Nandwana, Nitesh Kumar Nandwana, Yogarupa Das, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3402-3402
Open Access | Times Cited: 77
Gut-derived β-amyloid: Likely a centerpiece of the gut–brain axis contributing to Alzheimer’s pathogenesis
Jinghua Jin, Zhi Xu, Lina Zhang, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 67
Gut Microbiota, an Additional Hallmark of Human Aging and Neurodegeneration
Natalia Molinero, Alejandro Antón‐Fernández, Félix Hernández, et al.
Neuroscience (2023) Vol. 518, pp. 141-161
Open Access | Times Cited: 51
Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
Yadong Zheng, Laura Bonfili, Tao Wei, et al.
Nutrients (2023) Vol. 15, Iss. 21, pp. 4631-4631
Open Access | Times Cited: 47
The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline
James Melrose
Antioxidants (2023) Vol. 12, Iss. 3, pp. 663-663
Open Access | Times Cited: 42
Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti‐inflammatory activity, and the gut microbiota‐liver‐brain axis
James W. Daily, Suna Kang, Sunmin Park
BioFactors (2020) Vol. 47, Iss. 2, pp. 218-231
Closed Access | Times Cited: 110
The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside
Tomislav Meštrović, Mario Matijašić, Mihaela Perić, et al.
Diagnostics (2020) Vol. 11, Iss. 1, pp. 7-7
Open Access | Times Cited: 107
Curcumin and Its Derivatives as Theranostic Agents in Alzheimer’s Disease: The Implication of Nanotechnology
Umair Shabbir, Momna Rubab, Akanksha Tyagi, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 196-196
Open Access | Times Cited: 87
Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress?
Vivek Sharma, Thakur Gurjeet Singh, Nikhil Garg, et al.
Biomolecules (2021) Vol. 11, Iss. 5, pp. 678-678
Open Access | Times Cited: 85
Multi-pathogen infections and Alzheimer’s disease
Dana Vigašová, Michal Nemergut, Barbora Lišková, et al.
Microbial Cell Factories (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 81
Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications
Hyeon soo Kim, Sujin Kim, Soo Jung Shin, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 80
Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Agata Mulak
Journal of Alzheimer s Disease (2021) Vol. 84, Iss. 2, pp. 461-477
Open Access | Times Cited: 69
Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders
Meenakshi Kandpal, Omkar Indari, Budhadev Baral, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1064-1064
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top